Kyndryl Holdings, Inc. KD
Composite 42/100; the shares have moved about 50% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Balance-sheet strength ranks 27/100 — a moderate mark against it.
Valuation ranks 72/100 — a moderate point in its favour.
Balance-sheet strength ranks 27/100 — a moderate mark against it. Momentum ranks 30/100 — a moderate mark against it. Quality ranks 36/100 — a moderate mark against it.
What the company does Kyndryl Holdings provides IT infrastructure services including cloud, security, AI, and network solutions to industries like financial services, healthcare, and automotive. Its offerings span core enterprise services, digital workplace, and edge computing.
Key financials Revenue declined -0.8% YoY while EPS fell -73.1%. Margins are thin: gross 21.8%, operating 4.1%, net 1.3%. ROE is 15.1%, ROA 3.3%, ROCE 8.1%. Leverage is high with Debt/Equity at 3.84 and Net debt/EBITDA at 1.71.
Stock health Momentum is weak: -64.50% over 12m and -64.96% from the 52w high. RSI(14) is 70.70, suggesting overbought conditions. Sideravia scores Valuation 86.6 but Quality 38.5 and Momentum 19.2.
Price vs fair value The stock trades at a **PREMIUM of 2.93%** versus the analyst 12-month target of 13.60 and a **discount of 176.20%** versus our fair-value estimate of 38.69. - Recent headlines highlight mixed sentiment: "Stock Sinks As Market Gains" (Zacks) and "3 Value Stocks That Fall Short" (StockStory). - Approval of board and auditor at the annual meeting (MarketBeat) suggests governance stability. - "Why Kyndryl (KD) Stock Is Up Today" (StockStory) indicates episodic positive momentum.
Looking forward Forward P/E of 5.43 and EV/EBITDA of 3.16 imply deep value, but weak growth (-0.8% revenue) and high leverage raise execution risk. Analysts’ premium to target suggests limited near-term upside despite valuation appeal.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.